Pancreatic Adenocarcinoma

DBCOND0031512Digestive System DiseasesEndocrine System Diseases

Pancreatic Adenocarcinoma is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Adenocarcinoma of the Pancreas · Adenocarcinoma Pancreas · Adenocarcinoma of Pancreas · Pancreas, Adenocarcinoma · Adenocarcinoma, Pancreas
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT700423003MedDRA10051971UMLSC0281361

What you can answer from here — as of November 15, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
601Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Pancreatic Adenocarcinoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In